Skip to main content
Premium Trial:

Request an Annual Quote

California Licenses PGXL for Testing Services

NEW YORK (GenomeWeb) – PGXL Laboratories has received licensure from California to provide its testing services in the state.

As a result, the Louisville, Ky.-based company can offer its testing services in all 50 states in the US, it said. According to PGXL's website, it provides pharmacogenetic tests for CYP2C19, CYP2D6, Factor V Leiden, Factor II, and others. It also offers molecular oncology testing for the detection of EGFR, HER2/neu (fluorescent in situ hybridization), JAK2, ALK (FISH), and other genes.

PGXL operates as a commercial and research lab and said that in 2001 it was the first laboratory CLIA-certified specifically to offer pharmacogenetic tests.

The Scan

Time to Act

A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian.

Fulgent Seeking Defamation Suit

Fulgent Genetics says it plans to sue Los Angeles County Sheriff Alex Villanueva for defamation, the Los Angeles Times reports.

Speeding Gene-Edited Crops

Reuters reports that China's new trial rules will make it easier to grow gene-edited crops there.

Nucleic Acids Research Papers on Viral Recombination, Pan-Cancer Mutations, SARS-CoV-2 Variability

In Nucleic Acids Research this week: updated pipeline to detect viral recombination, mutational patterns in tumor samples, and more.